Colon cancer prevention: 50 and Fearless
Whether it's fear of the prep, the procedure or potential results, colonoscopy could be a lifesaver when detecting colon cancer, the second leading cancer killer in the U.S. That's why Scottsdale Healthcare launched its http://50andfearless.org/ health education campaign.
Although a screening colonoscopy is recommended starting at age 50, if there is a family history of colorectal cancer or polyps, screenings should begin at age 40.
The U.S. Centers for Disease Control and Prevention estimates that up to 60% of colorectal cancer deaths could be prevented if all men and women age 50 years and older were routinely screened.
Visit http://50andfearless.org/ and share the #50andFearless badge on social media to show you're ready to live more and fear less by getting a screening colonoscopy.
According to the American Cancer Society:
• Colon cancer is the second leading cancer killer for men and women in the U.S.
• 1 in 20 have a lifetime risk of developing colorectal cancer
• 102,480 new diagnoses of colon cancer are expected in 2013
• 50,830 colon cancer deaths expected during 2013
• There are 1 million colorectal cancer survivors in the U.S. thanks to early detection and treatment
Stand Up to Cancer: Virginia G. Piper Cancer Center at Scottsdale Healthcare
The Virginia G. Piper Cancer Center at Scottsdale Healthcare is one of the original Stand Up to Cancer Dream Team sites, studying new cancer treatments for pancreatic cancer.
Led by Dr. Daniel Von Hoff, the studies have shown encouraging results in improving quality of life and extending life expectancy for patients with advanced pancreatic cancer.
Hear Dr. Von Hoff's NPR interview about the Dream Teams: http://www.kjzz.org/content/1303/valley-physician-part-dream-teams-fighting-cancer
Virginia G. Piper Cancer Center Clinical Trials is a partnership between Scottsdale Healthcare and TGen that treats cancer patients with promising new drugs, and has built a national reputation for its drug development programs and treating advanced and rare cancers.
Individuals seeking information about clinical trials at the Virginia G. Piper Cancer Center at Scottsdale Healthcare (http://www.shc.org/clinicaltrials) may call 480-323-1339; toll free at 1-877-273-3713 or via email firstname.lastname@example.org.
Dr. Daniel Von Hoff Cancer Research at Scottsdale Healthcare
Dr. Daniel Von Hoff, chief scientific officer at the Virginia G. Piper Cancer Center at Scottsdale Healthcare, was keynote speaker at a recent special edition Scottsdale Mayor and Council Breakfast.
Dr. Von Hoff's presentation focused on the strides against cancer made at the Virginia G. Piper Cancer Center through its Phase I clinical trials and collaborations with TGen and other research partners.
For more information about the Virginia G. Piper Cancer Center at Scottsdale Healthcare, visit http://www.shc.org/cancer. For information about specific clinical trials currently open at the Virginia G. Piper Cancer Center, call 1-877-273-3713 or email email@example.com.
Follow us on Twitter at http://www.twitter.com/SHCpublicinfo and on Facebook at http://www.facebook.com/scottsdalehealthcare.
Get Your Gown On Prostate Cancer Awareness
Get Your Gown On is a new health education campaign from the Arizona-based Virginia G. Piper Cancer Center at Scottsdale Healthcare. Directing individuals to http://www.getyourgownon.org/, it aims to raise awareness about the need for regular prostate cancer screenings and the success of early detection and treatment of the disease.
The campaign features former Arizona State University football star, National Football League Hall of Famer and prostate cancer survivor Michael Haynes encouraging men 40 or older to have a prostate exam as part of an annual physical.
Haynes discovered he had prostate cancer following a screening exam in 2008. Now a prostate cancer survivor, he encourages men to talk with their doctors about getting tested for this deadly disease.
Statistics show prostate cancer is the most common cancer in American men. Without early diagnosis, one in 36 will die from the disease. Prostate cancer the second-leading cause of cancer death in men, behind lung cancer.
Visitors to http://www.getyourgownon.org/ can sign up for a free screening, read stories about Phoenix-area prostate cancer survivors, provide comments about prostate cancer detection and cancer treatment, and learn more about the innovative cancer treatment, research and support services available through the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
The nonprofit Virginia G. Piper Cancer Center at Scottsdale Healthcare established its leadership in personalized medicine by offering comprehensive cancer treatment, research, prevention and support services in a single location, working in collaboration with top community oncologists and scientists from leading universities and research institutions.
The nonprofit Virginia G. Piper Cancer Center holds Accreditation with Commendation from the Commission on Cancer of the American College of Surgeons. Accreditation with Commendation is awarded to top cancer programs demonstrating the highest levels of cancer clinical services, research, community outreach, quality improvement, leadership and data management, according to the Chicago-based Commission on Cancer. http://www.shc.org/cancer
Investigational cancer treatment study
A new investigational drug designed to stop cancer cells from reproducing may offer hope for patients with advanced solid tumor cancers. Clinical trials of TKM-PLK1 for qualified patients are now open at the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
TKM-PLK-1 targets a protein called polo-like kinase 1 (PLK1) that promotes tumor cell reproduction. It prevents the tumor from completing cell division, resulting in death of the cancer cell. The Virginia G. Piper Cancer Center at Scottsdale Healthcare will be among the first in the world to study the treatment in humans.
The new drug is being developed as a treatment for patients with advanced solid tumor cancers who are not well served by current therapy. The Phase 1 clinical trial will evaluate the safety, tolerability and how the body metabolizes TKM-PLK1.
Laboratory research showed the investigational compound may have effectiveness in treating colorectal, breast, non-small cell lung, and ovarian cancers. These diseases collectively affect more than 500,000 new patients each year in the United States.
Individuals seeking information about eligibility to participate in clinical trials at the Virginia G. Piper Cancer Center at Scottsdale Healthcare may contact the cancer care coordinator at 480-323-1339, toll free at 1-877-273-3713 or via email at firstname.lastname@example.org.
For more information about Virginia G. Piper Cancer Center Clinial Trials, visit http://www.shc.org/clinicaltrials.
Stand Up to Cancer
Pancreatic cancer clinical trials are underway at the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
The center is a primary clinical research site for the Stand Up to Cancer (SU2C) Dream Team pancreatic cancer research project.
Daniel Von Hoff, MD, chief scientific officer at the Virginia G. Piper Cancer Center at Scottsdale Healthcare and physician-in-chief at the Translational Genomics Research Institute (TGen), is co-leader of the Stand Up to Cancer pancreatic cancer Dream Team. Ramesh Ramanathan, MD is the medical director at Virginia G. Piper Cancer Center Clinical Trials.
"Cutting Off the Fuel Supply, A New Approach to the Treatment of Pancreatic Cancer" clinical trials include:
• Using a drug to break through the tough coating surrounding the cancer so a second drug can kill the cancer cells. This combination is showing positive preliminary results in actually shrinking tumors.
• Another effort is examining a tumor's molecular profile using state-of-the art molecular profiling techniques to personalize treatment for individual patients.
Cancer patients travel from across Arizona, the United States and beyond for treatment at the Virginia G. Piper Cancer Center at Scottsdale Healthcare. The center opened in 2001 as the first major cancer center in greater Phoenix to offer comprehensive cancer research, diagnosis, treatment, prevention and support services in a single location.
To learn about eligibility to participate in clinical trials at the Virginia G. Piper Cancer Center at Scottsdale Healthcare, contact the cancer care coordinator at 480-323-1339, toll free at 1-877-273-3713 or email@example.com.
For more information about current studies, visit http://www.shc.org/clinicaltrials.
Virginia G. Piper Cancer Center at Scottsdale Healthcare
The Virginia G. Piper Cancer Center at Scottsdale Healthcare opened in 2001 as the first major cancer center in greater Phoenix to offer comprehensive cancer research, diagnosis, treatment and support services in a single location at Scottsdale Healthcare Shea Medical Center.
Through our partnerships with community physicians, Scottsdale Healthcare Research Institute, the Translational Genomics Research Institute (TGen) and others, the patient and supportive care services you deserve have never been easier to access.
Our Cancer Care Coordinators are experienced advanced practice nurses with expertise in oncology. From the time youre diagnosed, this nurse coordinator is available as a dedicated member of your cancer care team and will facilitate personalized cancer care for you and your family.
Learn more at http://www.shc.org.
To contact a Cancer Care Coordinator,
Call: 480-323-1255 (toll free 1-877- 273-3639)
Cancer Clinical Trials Coordinator
Clinical trials offer hope for those with rare tumors and advanced cancers.
Cancer Clinical Trials Coordinators at the Virginia G. Piper Cancer Center at Scottsdale Healthcare are experienced RNs with advanced expertise in oncology. This is a free service offered by Scottsdale Healthcare to assist those with questions about participating in research studies of new cancer therapies.
Clinical trial participants have access to the latest drugs, procedures and other types of treatment. Although there is no guarantee that a new treatment will be effective, many trial participants conclude that the possible benefits outweigh the risks.
According to the National Institutes of Health, only 3% of adults participate in clinical trials. Studies show that if given the opportunity and access to clinical trials, 63% of the population would participate. Results of clinical trials may ultimately lead to FDA approval of new treatments for worldwide use.
The Clinical Trials Coordinator can help you and your family:
- Understand the types of research studies available.
- Provide information about eligibility and participation in clinical trials.
- Find answers to medical questions about your diagnosis.
- Communicate with your physicians, case managers and others.
- Help access available treatment and support resources through the Virginia G. Piper Cancer Center.
Contact the Clinical Trials Coordinator
Virginia G. Piper Cancer Center at Scottsdale Healthcare
Learn more at http://www.shc.org/clinicaltrials.
Toll free: 1-877-273-3713